ATF4 and cancer: Therefore, it was possible that cancer cells might gain superior capacity to uptake or utilize some AAs compared to the capability of normal cells via multiple signaling pathways, such as GCN2-ATF4 axis [72–75], or by decreasing AA catabolisms, such as BCAA [76].